// App-Quantinova.ai

SAT0346 (2018) : Clinically meaningful improvement in skin and nail psoriasis in bio-naÏve active psoriatic arthritis patients treated with intravenous golimumab: results through week 24 of the go-vibrant study

Researchers

Presenter

  • P.J. Mease

Principal Investigators

  • M.E. Husni

  • S.D. Chakravarty

  • S. Kafka

  • D.D. Harrison

  • D. Parenti

  • L. Kim

  • K.H. Lo

  • E.C. Hsia

  • A. Kavanaugh

Medical Centers

  • Swedish Medical Center and University of Washington School of Medicine, Seattle, WA

  • Cleveland Clinic, Cleveland, OH

  • Janssen Scientific Affairs, LLC/Drexel U School of Medicine, Horsham/Phila, PA

  • Janssen Scientific Affairs, LLC

  • Janssen Research & Development, LLC, Horsham, PA

  • Janssen Research and Development, LLC, Spring House, PA

  • Janssen Research and Development, LLC, Spring House, PA

  • UCSD, San Diego, CA

Locations

  • United States

  • United Kingdom

Companies

  • JB Medical Ltd.

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

  • Musculoskeletal

Disease

  • Psoriatic arthritis

  • Psoriasis

Biomarkers

  • C reactive protein

Drug/Treatment

  • golimumab

Outcome

  • N/A

Study Design

  • Randomized

  • Cross Over

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Janssen Research & Development

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved